• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

DCC-2036 (Rebastinib) Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS384600

DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity. More details

$175 / 5 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
DCC-2036 (Rebastinib), Inhibitor
Full Product Name
DCC-2036 (Rebastinib)
Product Synonym Names
DCC2036
Form/Format
Powder
Purity/Purification
>98%
Concentration
0.1 mM: 18.06 mL (1 mg); 90.32 mL (5 mg); 180.64mL (10 mg)
0.5 mM: 3.61 mL (1 mg); 18.06 mL (5 mg); 36.13 mL (10 mg)
1 mM: 1.81 mL (1 mg); 9.03 mL (5 mg); 18.06 mL (10 mg)
5 mM: 0.36 mL (1 mg); 1.81 mL (5 mg); 3.61 mL (10 mg) (lot specific)
Preparation and Storage
at -20 degree C 3 years Powder
Molecular Weight
553.59
CAS Number
1020172-07-9
Formula
C30H28FN7O3
SMILES
CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5
Actions
Inhibitor
In Vivo Solvent
0.5% CMC/0.25% Tween 80
Solubility (DMSO)
111 mg/mL (200.5 mM)
Solubility (Ethanol)
16 mg/mL (28.9 mM)
Solubility (in vivo)
16 mg/mL
Solubility (Water)
<1 mg/mL (<1 mM)
Availability
We cannot ship this item to Switzerland, Italy, Germany, France and Austria.

Chemical Structure of DCC-2036 (Rebastinib), inhibitor

DCC-2036 (Rebastinib) Inhibitor – Cat# MBS384600

Product References and Citations for DCC-2036 (Rebastinib), inhibitor

Hirosumi Tamura, .et al. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues, Oncol Rep, 2018, Aug; 40(2): 635-646 PMID: 29917168

Other Notes

Small volumes of DCC-2036 (Rebastinib), inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for DCC-2036 (Rebastinib) purchase

MBS384600 is an inhibitor targeting DCC-2036 (Rebastinib).
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000